PND9 Comparative Efficacy and Safety of Ozanimod Versus Teriflunomide for Relapsing-Remitting Multiple Sclerosis: A Matching-Adjusted Indirect Comparison

Saved in:
Bibliographic Details
Published inValue in health Vol. 23; p. S624
Main Authors Cohan, S., Kumar, J., Arndorfer, S., Zhu, X., Zivkovic, M., Tencer, T.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.12.2020
Online AccessGet full text

Cover

Author Kumar, J.
Cohan, S.
Zivkovic, M.
Tencer, T.
Arndorfer, S.
Zhu, X.
Author_xml – sequence: 1
  givenname: S.
  surname: Cohan
  fullname: Cohan, S.
  organization: Providence Multiple Sclerosis Center, Providence Brain and Spine Institute, Portland, NJ, USA
– sequence: 2
  givenname: J.
  surname: Kumar
  fullname: Kumar, J.
  organization: Bristol-Myers Squibb Company, Princeton, NJ, USA
– sequence: 3
  givenname: S.
  surname: Arndorfer
  fullname: Arndorfer, S.
  organization: Genesis Research, Hoboken, NJ, USA
– sequence: 4
  givenname: X.
  surname: Zhu
  fullname: Zhu, X.
  organization: Genesis Research, Hoboken, NJ, USA
– sequence: 5
  givenname: M.
  surname: Zivkovic
  fullname: Zivkovic, M.
  organization: Genesis Research, Hoboken, NJ, USA
– sequence: 6
  givenname: T.
  surname: Tencer
  fullname: Tencer, T.
  organization: Bristol-Myers Squibb Company, Princeton, NJ, USA
BookMark eNp9kMtu2zAQRYkgBfJovyAb_oDUISnSUoEuDDdtA-RRJEa2BEEOWwoSaZCyAedP-reV4Ky7mruYM7hzrsh5TBEJuWFQM2Dqc1_3BzPUHDjU0NZMiOaMXDLJm6pZCXE-Z-jaSgCTF-SqlB4AlODykvz99fito5s07kw2UzggvfU-WGOP1ERHX4zH6UiTp09vJoYxOfqKuewL3WIOftjHNAaH1KdMn3EwuxLi7-oZxzBNc6IP-2EKuwHpix0wpxLKF7qmD2ayf5bFtev3ZUJH76ILGe303iSUFD-SD94MBT-9z2uy_X673fys7p9-3G3W95VljWiqVsiGr5jzkmPrQHWtUl5KaBulVoDQKLYCxZjxzkpvOeMSpJFGNF3HmRTXRJzO2rleyej1LofR5KNmoBe5uteLXL3I1dDqRe5MfT1RODc7BMy62IDR4ukN7VL4L_8Pj8SGJw
ContentType Journal Article
Copyright 2020
Copyright_xml – notice: 2020
DBID 6I.
AAFTH
AAYXX
CITATION
DOI 10.1016/j.jval.2020.08.1334
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1524-4733
EndPage S624
ExternalDocumentID 10_1016_j_jval_2020_08_1334
S1098301520335907
GroupedDBID ---
--K
--M
.1-
.3N
.FO
.GA
.Y3
.~1
0R~
10A
123
1OC
1P~
1~.
29Q
31~
36B
4.4
44B
457
4G.
51W
51X
52N
52P
52R
52S
52X
53G
5LA
5VS
66C
6I.
6PF
7-5
7PT
8-1
8P~
8UM
AACTN
AAEDT
AAEDW
AAFJI
AAFTH
AAFWJ
AAHHS
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAPFB
AAQFI
AAQXK
AAWTL
AAXUO
ABBQC
ABCQN
ABDBF
ABEML
ABIVO
ABJNI
ABLVK
ABMAC
ABMMH
ABMZM
ABVKL
ABXDB
ABYKQ
ACCFJ
ACDAQ
ACGFS
ACHQT
ACPRK
ACRLP
ACXQS
ADBBV
ADEZE
ADFHU
ADMUD
AEBSH
AEEZP
AEKER
AENEX
AEQDE
AEVXI
AEXQZ
AEYQN
AFBPY
AFCTW
AFEBI
AFKWA
AFRHN
AFTJW
AFXIZ
AFZJQ
AGHFR
AGTHC
AGUBO
AGYEJ
AIEXJ
AIIAU
AIKHN
AITUG
AIWBW
AJAOE
AJBDE
AJBFU
AJOXV
AJRQY
AJUYK
AKYCK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AOMHK
ASPBG
AVARZ
AVWKF
AXJTR
AXLSJ
AZFZN
BAWUL
BFHJK
BKOJK
BLXMC
BNPGV
BY8
CAG
CO8
COF
CS3
DCZOG
DIK
DU5
EAD
EAP
EBS
EFJIC
EFLBG
EJD
EMB
EMK
EMOBN
ESX
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
GBLVA
HF~
HVGLF
HZI
HZ~
IHE
IXB
IXIXF
KOM
LCYCR
M41
MO0
N9A
NCXOZ
O-L
O9-
OAUVE
OK1
OVD
P-8
P-9
P2P
PC.
PQQKQ
PRBVW
Q38
QB0
R2-
RIG
ROL
SDF
SEL
SES
SPCBC
SSB
SSF
SSH
SSO
SSZ
SUPJJ
SV3
T5K
TEORI
TUS
W99
WYUIH
XG1
YFH
Z5R
~G-
0SF
AAXKI
AAYXX
ADVLN
AFJKZ
AKRWK
CITATION
OIG
ID FETCH-LOGICAL-c1434-8354271df52e8d069866f550846670e046170611afdc5fc212505a5a34992153
IEDL.DBID ABVKL
ISSN 1098-3015
IngestDate Thu Sep 26 16:17:20 EDT 2024
Fri Feb 23 02:40:15 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1434-8354271df52e8d069866f550846670e046170611afdc5fc212505a5a34992153
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S1098301520335907
ParticipantIDs crossref_primary_10_1016_j_jval_2020_08_1334
elsevier_sciencedirect_doi_10_1016_j_jval_2020_08_1334
PublicationCentury 2000
PublicationDate December 2020
2020-12-00
PublicationDateYYYYMMDD 2020-12-01
PublicationDate_xml – month: 12
  year: 2020
  text: December 2020
PublicationDecade 2020
PublicationTitle Value in health
PublicationYear 2020
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
SSID ssj0006325
Score 2.33169
SourceID crossref
elsevier
SourceType Aggregation Database
Publisher
StartPage S624
Title PND9 Comparative Efficacy and Safety of Ozanimod Versus Teriflunomide for Relapsing-Remitting Multiple Sclerosis: A Matching-Adjusted Indirect Comparison
URI https://dx.doi.org/10.1016/j.jval.2020.08.1334
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Bb9MwFLbGJiEuEwwQYzC9w7RTTZM4dpLdurKpZbRUtKDeIiexpVYjq9b2UA78D_4t7yUO3aRph52iOHHk-DnPn1--95mxE5nlRotQc6VkwsM8ElzbLOeyAruCrlUs36Hq_Qi_TOV0h3WbXBiiVTrfX_v0ylu7krbrzfZiNmuPfS-JcXjKwBNCJpRRvhcg-sWvc69z_vPq63-HrES19yrdz6lCIz5U0bzmaFBcJgYeKXnigi18eIK6M-lcvmT7Di1Cp27QK7ZjygP2fOD-hx-w01GtPL1pwWSbSLVswSmMtprUm9fs72j4OYHuVuobLkg7AmuCLgsYa2tWG7ix8O23LtF8BVAgbb2ECY5Qe72m5OXCACJcIPrcgiIM_Lv5Nato0zBwtEQYYzPxtWbLM-jAAN08Bbh4p5ivKawK_bLubtcSYjK9YZPLi0m3x92uDDxHbBVyihQFkV9YGZi48FQSK2VxnYNARkWeIQH3CEGCr22RS5vj1IggS0s0epIgvhBv2W55U5p3DEIbiUwJfJLRIQkIR4XJImPjwLdaGe-QtRpLpItaeyNtSGnzlAyXkuFSL07JcIdMNdZK7w2hFGeHxyq-f2rFI_aCTmt2ywe2u7pdm4-IUVbZMXv26Y9_7EYiHftXvSGW9qfn_wDH4ejj
link.rule.ids 315,783,787,3513,4509,24128,27581,27936,27937,45597,45675,45691,45886
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFLaqITEuExtMdBvjHdBO9ZrGsZNwq8qmFtZS0UzazXISW2q1ZdXaHroD_wf_Le_lhwoS4sA1tiPH7-n588v3PjP2UaaZNSIwXCkZ8yALBTcuzbgswa6gtpLlO1HD2-DLnbxrsUFTC0O0yjr2VzG9jNb1k269mt3lfN6d9bw4QveUvieEjKmi_EVA-Bid-vLHjuehRHnzKvXm1L2RHipJXgs0Jx4SfY90PPG4Fvx9e_pty7l-zQ5qrAj9ajqHrGWLI_ZyXP8NP2IX00p3etuBZFdGterABUx3itTbN-zndPI5hsFO6BuuSDkCR4IpcpgZZ9dbeHTw7dkUaLwcKI22WUGC_unuN1S6nFtAfAtEnltSfoF_tw_zkjQN45qUCDOcJn7WfPUJ-jDGIE_pLd7PFxtKqsKoqBa7ngnxmN6y5PoqGQx5fScDzxBZBZzyRH7Yy530bZR7Ko6UcnjKQRijQs-SfHuIEKFnXJ5Jl-HGiBDLSDR5HCO6EMdsr3gs7DsGgQtFqgS-yZqA5IPD3KahdZHfc0ZZr806jSX0slLe0A0lbaHJcJoMp71Ik-HaTDXW0n84kMa94V8DT_534Ae2P0zGN_pmNPl6yl5RU8VzOWN766eNfY9oZZ2el974Cxcn5xo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PND9+Comparative+Efficacy+and+Safety+of+Ozanimod+Versus+Teriflunomide+for+Relapsing-Remitting+Multiple+Sclerosis%3A+A+Matching-Adjusted+Indirect+Comparison&rft.jtitle=Value+in+health&rft.au=Cohan%2C+S.&rft.au=Kumar%2C+J.&rft.au=Arndorfer%2C+S.&rft.au=Zhu%2C+X.&rft.date=2020-12-01&rft.issn=1098-3015&rft.volume=23&rft.spage=S624&rft_id=info:doi/10.1016%2Fj.jval.2020.08.1334&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jval_2020_08_1334
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1098-3015&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1098-3015&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1098-3015&client=summon